Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pulmo Hevert Bronchialcomplex is a homeopathic medicine developed by Hevert-Arzneimittel for the relief of respiratory tract inflammation, bronchitis, and associated symptoms such as dry, spasmodic, or productive coughs and hoarseness. Available in both tablet and drop formulations, it contains a synergistic combination of multiple homeopathic active substances (including Drosera, Grindelia robusta, Kalium jodatum, Naphthalinum, Spongia, Sticta, Teucrium scorodonia, Verbascum, and Yerba santa in the tablet form; and Ammi visnaga, Belladonna, Corallium rubrum, Cuprum metallicum, Grindelia robusta, Lobelia inflata, and Sticta in the drops form). These ingredients work together to soothe the airways, relieve bronchial spasms, reduce excessive mucus production, and facilitate expectoration without suppressing the central cough reflex.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pulmo Hevert Bronchialcomplex.